The first three authors contributed equally to the workHelicobacter pylori infection induces a chronic gastric inflammatory infiltrate. This study was undertaken to evaluate the type of the innate immune responses elicited by the secreted peptidyl-prolyl cis-trans isomerase of H. pylori (HPOI75). The cytokine production induced by HPOl75 in neutrophils, and monocytes was evaluated. HPOl75 was able to induce the expression of IL-23 in neutrophils, and monocytes, and IL-6, IL-Ibeta and TGF-beta in monocytes. These findings indicate that HPOl75 is able to promote the activation of innate cells and the production of a cytokine milieu that may favour the development ofThl7 response.Helicobacter pylori (H. pylori) is a spiral-shaped Gram-negative bacterium that chronically infects the stomach of more than 50% of the human population and represents the major cause of gastric cancer, gastric lymphoma, gastric autoimmunity and peptic ulcer diseases (1-5). The World Health Organization classifies H. pylori as a type I carcinogen for distal gastric cancer. Eradicating the bacterium, in high risk populations, reduces incidence of gastric cancer (6). H. pylori induces an inflammatory response in the gastric mucosa characterized by polymorphonuclear and mononuclear cell infiltration. The host immune response to H. pylori influences the clinical outcome of the infection. Following H. pylori infection, innate and acquired immune responses take place in the stomach and are characterized by activation of macrophages and dendritic cells, production of antibodies, and by differentiation and activation of T helper 1 (Thl) cells (7-9). However, emerging experimental evidence indicates that H. pylori promotes also the development of the Th 17 subset (10-12). Interleukin (IL)-1b, IL-6, transforming growth factor-b (TGF-b), and IL-23 are key cytokines in the differentiation and expansion of Th 17 cells (13,14). IL-17, IL-21 and IL-23 are up-regulated in H. pylori-infected gastric mucosa (10, 15).